Holen Sie sich die Stockscreener-App
28.54
0.63%
-0.13
Schlusskurs vom Vortag:
$28.67
Offen:
$28.65
24-Stunden-Volumen:
1,001
Relative Volume:
0.01
Marktkapitalisierung:
$454.47M
Einnahmen:
$72.30M
Nettoeinkommen (Verlust:
$-6.12M
KGV:
-15.52
EPS:
-1.8384
Netto-Cashflow:
$-41.16M
1W Leistung:
+3.56%
1M Leistung:
-3.72%
6M Leistung:
+15.48%
1J Leistung:
+163.55%
1-Tages-Spanne:
$28.65
$28.65
1-Wochen-Bereich:
$27.50
$30.18
52-Wochen-Spanne:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
28.65 | 454.78M | 72.30M | -6.12M | -41.16M | -1.8384 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Analyst Patrick R. Trucchio Reiterates Buy Rating for ASMB | ASM - GuruFocus
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences (ASMB) launches $100M ATM via Jefferies under $400M shelf - Stock Titan
Assembly Biosciences: Fourth Quarter Financial Results Overview - Bitget
Assembly Biosciences: Q4 Earnings Snapshot - marketscreener.com
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - The Manila Times
Assembly Biosciences 2025 net loss narrows - TradingView
Assembly Biosciences (NASDAQ: ASMB) advances antiviral pipeline and expands Gilead deal - Stock Titan
ASMB: 2025 revenue jumped to $72.3M, net loss shrank to $6.1M, and cash reserves rose to $248.1M - TradingView
Assembly Biosciences (Nasdaq: ASMB) slashes 2025 loss as Gilead deal lifts revenue - Stock Titan
Gilead deal hands Assembly Bio $35M as herpes program advances - Stock Titan
Panic Selling: Is Assembly Biosciences Inc being accumulated by smart money2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Risk Analysis: Can Assembly Biosciences Inc stock double in the next yearQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assembly Biosciences Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Farallon Capital Management LLC Takes $31.43 Million Position in Assembly Biosciences, Inc. $ASMB - MarketBeat
Commodore Capital LP Purchases Shares of 1,000,000 Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (ASMB) Projected to Post Earnings on Thursday - MarketBeat
Precision Trading with Assembly Biosciences Inc. (ASMB) Risk Zones - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Stock Report: Is Tecnoglass Inc forming a bullish divergenceWeekly Gains Report & Safe Entry Point Identification - baoquankhu1.vn
Published on: 2026-03-10 01:27:50 - baoquankhu1.vn
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes - MSN
ASMB Earnings History & Surprises | EPS & Revenue Results | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Assembly Biosciences identifies new compounds for HSV infection - bioworld.com
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
Patient Square Capital LP Invests $3.46 Million in Assembly Biosciences, Inc. $ASMB - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Will Assembly Biosciences Inc. stock benefit from infrastructure spendingWeekly Investment Recap & Safe Swing Trade Setup Alerts - mfd.ru
What is the target price for Assembly Biosciences Inc. stockQuarterly Market Review & AI Powered Buy and Sell Recommendations - mfd.ru
Trading the Move, Not the Narrative: (ASMB) Edition - Stock Traders Daily
Take Profit: Is Assembly Biosciences Inc stock trending bullishMarket Risk Report & Safe Capital Growth Plans - baoquankhu1.vn
Is Assembly Biosciences Inc. benefiting from innovation trendsLayoff News & Safe Entry Point Identification - mfd.ru
ASMB PE Ratio & Valuation, Is ASMB Overvalued - Intellectia AI
What is Assembly Biosciences Inc. s 5 year growth outlookJuly 2025 PostEarnings & Low Risk High Reward Ideas - mfd.ru
Bearish Setup: Can Assembly Biosciences Inc stock double in the next yearJuly 2025 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):